Moderna, Inc. (MRNA)
218.01
-18.49
(-7.82%)
USD |
NASDAQ |
Oct 16, 16:00
215.19
-2.82
(-1.29%)
After-Hours: 20:00
Moderna Cash from Investing (Quarterly) : 329.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 329.00M |
| March 31, 2026 | -76.00M |
| December 31, 2025 | -48.00M |
| September 30, 2025 | 700.00M |
| June 30, 2025 | 564.00M |
| March 31, 2025 | 730.00M |
| December 31, 2024 | -539.00M |
| September 30, 2024 | 721.00M |
| June 30, 2024 | 1.649B |
| March 31, 2024 | 118.00M |
| December 31, 2023 | -538.00M |
| September 30, 2023 | 789.00M |
| June 30, 2023 | 1.944B |
| March 31, 2023 | 2.011B |
| December 31, 2022 | -1.048B |
| September 30, 2022 | 945.00M |
| June 30, 2022 | -1.152B |
| March 31, 2022 | -3.921B |
| Date | Value |
|---|---|
| December 31, 2021 | -1.138B |
| September 30, 2021 | -3.327B |
| June 30, 2021 | -3.878B |
| March 31, 2021 | -180.00M |
| December 31, 2020 | -190.13M |
| September 30, 2020 | -1.178B |
| June 30, 2020 | 12.48M |
| March 31, 2020 | -316.02M |
| December 31, 2019 | 130.35M |
| September 30, 2019 | 113.37M |
| June 30, 2019 | -246.90M |
| March 31, 2019 | -11.76M |
| December 31, 2018 | 6.409M |
| September 30, 2018 | 116.08M |
| June 30, 2018 | -11.26M |
| March 31, 2018 | -483.70M |
| December 31, 2017 | 112.80M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.659B |
| Vaxcyte, Inc. | 147.72M |
| Twist Bioscience Corp. | -10.20M |
| BioNTech SE | -118.82M |
| Vir Biotechnology, Inc. | -197.14M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -526.00M |
| Cash from Financing (Quarterly) | 14.00M |
| Free Cash Flow | -1.244B |
| Free Cash Flow Per Share (Quarterly) | -1.415 |
| Free Cash Flow to Equity (Quarterly) | -552.00M |
| Free Cash Flow to Firm (Quarterly) | -545.67M |
| Free Cash Flow Yield | -1.45% |